| Page 1800 | Kisaco Research
 

Dr. Christina Coughlin

Chief Medical Officer & Executive Vice President
Tmunity

Dr. Christina Coughlin

Chief Medical Officer & Executive Vice President
Tmunity

Dr. Christina Coughlin

Chief Medical Officer & Executive Vice President
Tmunity
 

Dr. John McHutchinson

Chief Scientific Officer, Head of Research and Development
Gilead

Dr. John McHutchinson

Chief Scientific Officer, Head of Research and Development
Gilead

Dr. John McHutchinson

Chief Scientific Officer, Head of Research and Development
Gilead
 

Dr. Alessandro Riva

Executive Vice President, Oncology Therapeutics
Gilead

Dr. Alessandro Riva

Executive Vice President, Oncology Therapeutics
Gilead

Dr. Alessandro Riva

Executive Vice President, Oncology Therapeutics
Gilead
 
Microbiome Invest 2019
23 May 2019
London
Microbiome Invest 2019 is dedicated to showcasing the most innovative emerging companies and academics with commercially viable research that manipulates the microbiome. Active investors and multinational nutrition and health companies will also share their knowledge and perspectives on commercialisation and discuss the most cutting-edge products and research in the microbiome space.
Pet Retail Strategies
Spotlight on...FitSkin
 

Samuel Bjork

Principal
Digitalis Ventures

Samuel Bjork

Principal
Digitalis Ventures

Samuel Bjork

Principal
Digitalis Ventures